Infliximab as monotherapy in giant cell arteritis.

Authors	Imad Uthman, Nadim Kanj, Samir Atweh
Journal	Clinical rheumatology (Clin Rheumatol) Vol. 25 Issue 1 Pg. 109-10 (Feb 2006) ISSN: 0770-3198 [Print] Germany
PMID	15902519 (Publication Type: Case Reports, Letter)
Chemical References	Antibodies, Monoclonal Antirheumatic Agents Tumor Necrosis Factor-alpha Infliximab
Topics	Aged Antibodies, Monoclonal (therapeutic use) Antirheumatic Agents (therapeutic use) Female Giant Cell Arteritis (drug therapy) Humans Infliximab Treatment Outcome Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!